Plunkett Research Online: Avrobio Inc

AVROBIO INC (AVRO) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea.....


AVROBIO INC

Ticker: AVRO
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 914-8420
Fax:
Address: One Kendall Square Building 300, Suite 201
Cambridge, MA 2139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Erik OstrowskiCEO/CFO/Chief Accounting Officer/President/Treasurer
Bruce BoothChairman of the Board/Director
See More
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture